Inactivated Polio Vaccine (ipv) - Vaccines

Relevant Publications

Effectiveness of poliovirus vaccines against circulating vaccine-derived type 2 poliomyelitis in Nigeria between 2017 and 2022: a case-control study.

Issue Release: 2024

Inactivated Poliovirus Vaccine: Recent Developments and the Tortuous Path to Global Acceptance.

Issue Release: 2024

Modeling undetected poliovirus circulation following the 2022 outbreak in the United States.

Issue Release: 2024

Trade-offs of different poliovirus vaccine options for outbreak response in the United States and other countries that only use inactivated poliovirus vaccine (IPV) in routine immunization.

Issue Release: 2024

Immunogenicity and safety of adsorbed diphtheria-purified pertussis-tetanus-inactivated polio (Sabin strain)-Haemophilus type b conjugate combined vaccine (DPT-IPV-Hib) in healthy Japanese Infants ≥ 2 and < 43 months of Age: A phase III, multicenter, active controlled, assessor-blinded, randomized, parallel-group study.

Issue Release: 2024

Intestinal mucosal immunity is unimportant for polio eradication: the failure of oral polio vaccination.

Issue Release: 2024

Monitoring the evolution of vaccine-derived poliovirus in East and Southern African countries, 2010 - 2021.

Issue Release: 2024

Exploring the path to polio eradication: insights from consecutive seroprevalence surveys among Pakistani children.

Issue Release: 2024

Immune persistence after different polio sequential immunization schedules in Chinese infants.

Issue Release: 2024

The Immunogenicity of Monovalent Oral Poliovirus Vaccine Type 1 (mOPV1) and Inactivated Poliovirus Vaccine (IPV) in the EPI Schedule of India.

Issue Release: 2024

Nasal and pharyngeal mucosal immunity to poliovirus in children following routine immunization with inactivated polio vaccine (IPV) in the United States of America.

Issue Release: 2024

Estimation of the poliovirus type 2 immunity gap in South Africa.

Issue Release: 2024

Cost minimization analysis of a hexavalent vaccine in Argentina.

Issue Release: 2023

Neutralizing anti-polio antibody titre in newborn babies in post-polio eradication period in Nigeria.

Issue Release: 2023

Vaccine-derived poliovirus serotype 2 outbreaks and response in the Democratic Republic of the Congo, 2017-2021.

Issue Release: 2023

Threat of resurgence or hope for global eradication of poliovirus?

Issue Release: 2023

Immunogenicity and Safety of a Hexavalent DTwP-IPV-HB-PRP~T Vaccine Versus Separate DTwP-HB-PRP~T, bOPV, and IPV Vaccines Administered at 2, 4, 6 Months of Age Concomitantly With Rotavirus and Pneumococcal Conjugate Vaccines in Healthy Infants in Thailand.

Issue Release: 2023

Analysis of a Sabin-Strain Inactivated Poliovirus Vaccine Response to a Circulating Type 2 Vaccine-Derived Poliovirus Event in Sichuan Province, China 2019-2021.

Issue Release: 2023

Persistence of immunity following a single dose of inactivated poliovirus vaccine: a phase 4, open label, non-randomised clinical trial.

Issue Release: 2023

Dose-sparing effect of Sabin-derived inactivated polio vaccine produced in Japan by intradermal injection device for rats.

Issue Release: 2023

Why is Cold Chain Logistics Important for Vaccines?

What is Healthcare Management in the Context of Vaccines?

Can Vaccines Overwhelm the Immune System?

What is Influenza?

What are the Benefits of Vaccination?

How Are Vaccines Administered?

What Are the Long-term Implications?

How Does WHO Address Vaccine Hesitancy?

How Long Does Preclinical Testing Take?

Why is Malaria a Significant Health Issue?

Inactivated Polio Vaccine (ipv) - Vaccines

Relevant Publications

Partnered Content Networks

Relevant Topics